Clinical Treatment of Heart Failure Flashcards

1
Q

What are the major goals of therapy?

A

↑ quantity of life (improve survival)
↑ quality of life (reduce symptoms)
Decrease societal / financial burden of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How to therapeutically approach HF?

A

-Correction of the underlying cause of HF
-Elimination of precipitating factors (infection, anemia, etc)
-Reduction of congestion
-Improve blood flow:
Modulate neurohormal activation
Devices / transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What lab studies could rule out reversible causes of HF?

A
  • Vitals BP / HR (hypertension)
  • EKG (tachyarrhythmia, AFib, PVCs)
  • CMP, CBC (renal failure, liver dysfunction, anemia, infxn)
  • CXR (coexistant lung disease, for future comparison)
  • BNP / NT-proBNP, troponin (prognosis)
  • Echo (dilation, LV function, wall motion, PHTN, prognosis)
  • Coronary angiogram v. CTA, stress testing, MRI (ischemia, scar)
  • Thyroid function tests
  • Iron studies (hemochromatosis, iron deficiency)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do you reduce congestion?

A

Diuretics, Reverses fluid retention (Na loss)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The most common HF therapy

A

Diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharmacokinetics of diuretics

A

Can be used chronically and acutely
Typically PO dose at baseline
Often use IV in the hospital (PO not absorbed, worsening renal function, also need higher dose)
Side effects: dehydration, hypokalemia, sulfa, tinnitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diuretics method of action

A

increase Salt (+Water) Excretion->decrease Intravasc Fluid Vol->decrease Venous Congestion->decrease dyspnea/edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are ACE inhibitors?

A
  • …prils (lisinopril, enalapril, benazepril)

- Block conversion of ATI to ATII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Effects of ACEIs

A

Direct vasodilation

Decreased aldosterone activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Side effects of ACEIs

A

Hypotension
Worsening renal function (afferent vasocontraction)
Hyperkalemia
Cough (kinin potentiation): ~20%
Angioedema: <1%, can occur after months of use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are ARBs?

A
  • …sartans (e.g. valsartan, candesartan, losartan)

- Effect: Block the receptor of angiotensin II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical use of ARBs

A
  • In studies have been equivalent to ACEI
  • Controversial whether use in combination (ARB + ACEI) provides added benefit
  • Generally used when patients develop cough to ACEI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Side effects of ARBs

A

ARBs do not produce kinin potentiation (no cough)

Otherwise side effects are similar to ACEI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are Mineralocorticoid Receptor Antagonists (MRA)?

A

-Spironolactone and eplerenone
-Effect: Block mineralocorticoid receptor
Kidney: ACEI/ARB aldosterone block is incomplete
Produces additional sodium loss (diuretic), Antifibrotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Side effects of MRAs

A

Hyperkalemia (requires close monitoring)

Gynecomastia (spiro only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are beta-blockers?

A
  • olols (metoprolol, carvedilol, bisoprolol)
  • Effect: Antagonize effect of sypathetic system (epinephrine/norepinephrine)
  • β1 blockade:
  • Negative chronotrope (slow heart rate, less arrhythmia)
  • Negative inotrope (decreased metabolic demand)
  • [α1 blockade: vasodilation]
17
Q

Side effects of beta-blockers

A

Negative inotrope: short-term loss for long-term gain
Fluid retention
Hypotension
Decreased cardiac output, even cardiogenic shock
Bronchoconstriction

18
Q

End result of Adrenergic and RAAS blockers?

A
-Anti-Remodeling Decreased:
Hypertrophy
Fibrosis
Apoptosis
-All 3 REDUCE MORBIDITYAND IMPROVE SURVIVAL
19
Q

What are the different Vasodilators for HF?

A
Arterial vasodilation (antihypertensives)
Venous vasodilation (venodilators)
Pulmonary arterial vasodilation
20
Q

Effect of pulmonary arterial vasodilation

A

Decrease in RV afterload

21
Q

Effect of Venous vasodilation (venodilators)

A

Decrease in preload

22
Q

Benefits of arterial vasodilatation

A

Decrease in LV afterload
Reduced cardiac work
Less mitral regurgitation

23
Q

Use of Hydralazine / isosorbide dinitrate in HFREF

A

Hyd/ISDN < ACEI (V-HeFT II)

Hyd/ISDN+ACEI/BB in blacks good (A-HeFT)

24
Q

What is an ICD?

A

Implanted Cardioverter Defibrillators
Patients with LVEF <=35% or prior dangerous heart rhythms
Abort sudden cardiac death from ventricular tachycardia / fibrillation

25
What is CRT therapy?
Cardiac Resynchronization Therapy Biventricular pacemakers (CRT or BiV) LV lead placed through the coronary sinus
26
Indication for CRT use
For patients with QRS duration > 120 msec (bundle brank block)
27
CRT mechanism of action
Cause the LV lateral wall and septal wall to contract together, which produces a more efficient contraction / ↑ stroke volume Usually placed with ICD
28
Rx options for chronic (stable) HFrEF
``` BB ACEI/ARB Aldosterone antagonist Hydralazine / ISDN +/-Digoxin ICD/CRT ```
29
Rx options for Acute decompensated HF
IV diuretics IV vasodilators (nitrates / nitroprusside, if BP allows) Positive pressure ventilation (CPAP/BiPAP, intubation) for hypoxia May also reduce preload IV inotropes for shock only May need to cut back on beta-blockers (only in severe cases)
30
Types of Positive Inotropic Agents
Digoxin (PO) - K/Na exchange Dobutamine (IV) – β agonist (opposite of BB) Milrinone (IV) – phosphodiesterase inhibitor (effect is similar to dobutamine)
31
Clinical use of positive inotropic agents
ACUTE: IV agents used short term to reverse shock Long-term they worsen remodeling CHRONIC: Digoxin has no effect on mortality but may reduce symptoms and hospitalization (also some decrease in heart rate in AFib) In high doses causes dig toxicity (mostly arrhythmias)
32
T or F: inotropic agents Improve symptoms short-term | Long-term HF is worsened
True
33
Beta-Agonism v. Antagonism:
ACUTE v. CHRONIC, respectively
34
Stages of HF
Asymptomatic HF (late “prevention”) Chronic stable HF (ambulatory) Acute decompensated HF (hospitalized) End-stage heart failure (advanced)
35
What is LVAD?
Left Ventricular Assistance Device mechanical circulatory device that is used to partially or completely replace the function of a failing heart, can be used in CHF
36
Options for end-stage HFrEF
Transplant LVAD Inotrope infusion Hospice
37
What can you do to improve Sx in HFrEF?
``` Diuretics (furosemide) Digitalis PO (HFrEF with shock - dobutamine, milronone) ```
38
What can you do to prolong survival in HFrEF?
ACE Inhibitors / Angiotensin Receptor Blockers Beta Blockers Aldosterone Receptor Antagonists Other Vasodilators (hydralazine + nitrates) Cardiac Resynchronization Therapy (biventricular pacing) Implantable Cardioverter Defibrillator (ICD)
39
Therapy for HFpEF
- treating the underlying disorder (hypertension, diabetes, kidney dysfunction) - Diuretics are used to keep volume normal (sodium retention is common) - Vasodilators are used to maintain normal blood pressure - neurohormonal antagonists (e.g. ACEI, ARB) not successful